Cargando…
Thalassemia and hepatocellular carcinoma: links and risks
The increased survival and lifespan of thalassemia patients, in the setting of better iron overload monitoring and chelation, have also however increased the incidence of diseases and complications, which were less likely to develop. Among these, one of the most worrying in recent years is hepatocel...
Autores principales: | Marsella, Maria, Ricchi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756274/ https://www.ncbi.nlm.nih.gov/pubmed/31572038 http://dx.doi.org/10.2147/JBM.S186362 |
Ejemplares similares
-
Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
por: Ricchi, Paolo, et al.
Publicado: (2015) -
Special Issue: “Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management”
por: Ricchi, Paolo, et al.
Publicado: (2022) -
Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022) -
Non-Transfusion-Dependent Thalassemia: A Complex Mix of Genetic Entities Yet to Be Fully Discovered
por: Ricchi, Paolo, et al.
Publicado: (2015) -
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
por: Mangia, Alessandra, et al.
Publicado: (2020)